Patents by Inventor Naijie Jing

Naijie Jing has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • G-quartet oligonucleotides that target hypoxia-inducible factor 1-? (HIF1?)
    Patent number: 8168603
    Abstract: The present invention concerns particular G-quartet oligonucleotides that are employed for the treatment and/or prevention of cancer. In specific cases, the G-quartet oligonucleotides inhibit HIF-1?.
    Type: Grant
    Filed: May 9, 2008
    Date of Patent: May 1, 2012
    Assignee: Baylor College of Medicine
    Inventors: Naijie Jing, Yongli Guan
  • G-QUARTET OLIGONUCLEOTIDES THAT TARGET HYPOXIA-INDUCIBLE FACTOR 1-a (HIF1a )
    Publication number: 20090075928
    Abstract: The present invention concerns particular G-quartet oligonucleotides that are employed for the treatment and/or prevention of cancer. In specific cases, the G-quartet oligonucleotides inhibit HIF-1?.
    Type: Application
    Filed: May 9, 2008
    Publication date: March 19, 2009
    Applicant: Baylor College of Medicine
    Inventors: Naijie Jing, Yongli Guan
  • Technology of intracellular delivery of DNA oligonucleotides to improve drug activity
    Patent number: 7119078
    Abstract: The present invention relates to methods of intracellular delivery of oligonucleotides. More particularly, the present invention relates to the use of the delivery system to deliver G-quartet oligonucleotides as a cancer therapy or an anti-viral therapy.
    Type: Grant
    Filed: March 27, 2002
    Date of Patent: October 10, 2006
    Assignee: Baylor College of Medicine
    Inventors: Naijie Jing, Weijun Xiong, Yongli Guan
  • NOVEL TECHNOLOGY OF INTRACELLULAR DELIVERY OF DNA OLIGONUCLEOTIDES TO IMPROVE DRUG ACTIVITY
    Publication number: 20060199777
    Abstract: The present invention relates to methods of intracellular delivery of oligonucleotides. More particularly, the present invention relates to the use of the delivery system to deliver G-quartet oligonucleotides as a cancer therapy or an anti-viral therapy.
    Type: Application
    Filed: March 27, 2002
    Publication date: September 7, 2006
    Inventors: Naijie Jing, Weijun Xiong, Yongli Guan